Back to results
US 9,580,698 B1Granted
Mutant reverse transcriptase
AssigneeNew England Biolabs, Inc.
InventorsYan Xu, Jennifer Ong, Shengxi Guan, Nicole Nichols
Life of this patent
Estimating the term…
Abstract
A mutant MMLV reverse transcriptase that may have an improvement in one or more properties is provided. For example, the present reverse transcriptase is believed to be more efficient relative to other commercially available MMLV reverse transcriptase variants, particularly for templates with a higher GC content.
Claims10
A polypeptide comprising at least 300 contiguous amino acids of SEQ ID NO:1.
Dependencies are inferred from the claim text.